US2648609A
(en)
|
1949-01-21 |
1953-08-11 |
Wisconsin Alumni Res Found |
Method of applying coatings to edible tablets or the like
|
NO98434A
(pt)
*
|
1959-04-30 |
|
|
|
US3117027A
(en)
*
|
1960-01-08 |
1964-01-07 |
Wisconsin Alumni Res Found |
Apparatus for coating particles in a fluidized bed
|
US3207824A
(en)
|
1962-06-22 |
1965-09-21 |
Wisconsin Alumni Res Found |
Process for preparing agglomerates
|
US3196827A
(en)
|
1962-11-19 |
1965-07-27 |
Wisconsin Alumni Res Found |
Apparatus for the encapsulation of discrete particles
|
US3253944A
(en)
*
|
1964-01-13 |
1966-05-31 |
Wisconsin Alumni Res Found |
Particle coating process
|
US3241520A
(en)
*
|
1964-10-19 |
1966-03-22 |
Wisconsin Alumni Res Found |
Particle coating apparatus
|
US4419340A
(en)
|
1969-03-24 |
1983-12-06 |
University Of Delaware |
Controlled release of anticancer agents from biodegradable polymers
|
US4344431A
(en)
|
1969-03-24 |
1982-08-17 |
University Of Delaware |
Polymeric article for dispensing drugs
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
US4069307A
(en)
*
|
1970-10-01 |
1978-01-17 |
Alza Corporation |
Drug-delivery device comprising certain polymeric materials for controlled release of drug
|
US4351337A
(en)
|
1973-05-17 |
1982-09-28 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery device, and process for preparing and using the same
|
US4450150A
(en)
*
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
US3978203A
(en)
|
1974-07-12 |
1976-08-31 |
Dynatech Corporation |
Sustained release of pharmaceuticals from polyester matrices
|
US4093709A
(en)
|
1975-01-28 |
1978-06-06 |
Alza Corporation |
Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
|
US4134742A
(en)
*
|
1977-06-06 |
1979-01-16 |
Envirogenic Systems Company |
Gas separation membranes
|
US4186189A
(en)
*
|
1977-09-28 |
1980-01-29 |
Ethicon, Inc. |
Absorbable pharmaceutical compositions based on poly(alkylene oxalates)
|
US4249531A
(en)
*
|
1979-07-05 |
1981-02-10 |
Alza Corporation |
Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
|
US4346709A
(en)
|
1980-11-10 |
1982-08-31 |
Alza Corporation |
Drug delivery devices comprising erodible polymer and erosion rate modifier
|
IE52535B1
(en)
*
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
IN156886B
(pt)
|
1981-08-22 |
1985-11-30 |
Council Scient Ind Res |
|
US5310559A
(en)
|
1982-09-01 |
1994-05-10 |
Hercon Laboratories Corporation |
Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
|
CH661206A5
(fr)
*
|
1983-09-23 |
1987-07-15 |
Debiopharm Sa |
Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
|
US4623588A
(en)
|
1984-02-06 |
1986-11-18 |
Biotek, Inc. |
Controlled release composite core coated microparticles
|
US4568559A
(en)
*
|
1984-02-06 |
1986-02-04 |
Biotek, Inc. |
Composite core coated microparticles and process of preparing same
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
US6217911B1
(en)
*
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
CH671337A5
(pt)
*
|
1984-06-19 |
1989-08-31 |
Ceskoslovenska Akademie Ved |
|
US4657543A
(en)
*
|
1984-07-23 |
1987-04-14 |
Massachusetts Institute Of Technology |
Ultrasonically modulated polymeric devices for delivering compositions
|
US4650665A
(en)
*
|
1985-02-08 |
1987-03-17 |
Ethicon, Inc. |
Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
|
US4863735A
(en)
|
1985-02-19 |
1989-09-05 |
Massachusetts Institute Of Technology |
Biodegradable polymeric drug delivery system with adjuvant activity
|
US4720384A
(en)
*
|
1985-05-03 |
1988-01-19 |
E. I. Du Pont De Nemours And Company |
Manufacture of hollow fine tubular drug delivery systems
|
DE3521684A1
(de)
*
|
1985-06-18 |
1986-12-18 |
Dr. Müller-Lierheim KG, Biologische Laboratorien, 8033 Planegg |
Verfahren zur beschichtung von polymeren
|
US4976949A
(en)
|
1985-10-25 |
1990-12-11 |
The University Of Michigan |
Controlled release dosage form
|
DE3542972A1
(de)
|
1985-12-05 |
1987-06-11 |
Merck Patent Gmbh |
Pharmakadepot
|
US4794001A
(en)
|
1986-03-04 |
1988-12-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
IT1204294B
(it)
*
|
1986-03-11 |
1989-03-01 |
Gentili Ist Spa |
Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
|
CA1257199A
(en)
*
|
1986-05-20 |
1989-07-11 |
Paul Y. Wang |
Preparation containing bioactive macromolecular substance for multi-months release in vivo
|
EP0246795A3
(en)
*
|
1986-05-20 |
1990-04-04 |
Advanced Peptide Development Limited |
Synthetic natriuretic peptides
|
US4832686A
(en)
*
|
1986-06-24 |
1989-05-23 |
Anderson Mark E |
Method for administering interleukin-2
|
US4839130A
(en)
|
1986-07-17 |
1989-06-13 |
United States Surgical Corporation |
Process of making an absorbable surgical device
|
US5322691A
(en)
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
US4981696A
(en)
*
|
1986-12-22 |
1991-01-01 |
E. I. Du Pont De Nemours And Company |
Polylactide compositions
|
CH668553A5
(de)
*
|
1987-02-02 |
1989-01-13 |
Mepha Ag |
Arzneimittel mit verzoegerter wirkstofffreisetzung.
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
US5114719A
(en)
*
|
1987-04-29 |
1992-05-19 |
Sabel Bernhard A |
Extended drug delivery of small, water-soluble molecules
|
US4792448A
(en)
|
1987-06-11 |
1988-12-20 |
Pfizer Inc. |
Generic zero order controlled drug delivery system
|
US4952403A
(en)
|
1987-06-19 |
1990-08-28 |
President And Fellows Of Harvard College |
Implants for the promotion of healing of meniscal tissue
|
US5013553A
(en)
*
|
1987-06-30 |
1991-05-07 |
Vipont Pharmaceutical, Inc. |
Drug delivery devices
|
US4894231A
(en)
*
|
1987-07-28 |
1990-01-16 |
Biomeasure, Inc. |
Therapeutic agent delivery system
|
US4897268A
(en)
*
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
DE19975054I2
(de)
|
1987-08-08 |
2000-04-13 |
Akzo Nobel Nv |
Kontrazeptives Implantat
|
GB2209937B
(en)
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US5035891A
(en)
|
1987-10-05 |
1991-07-30 |
Syntex (U.S.A.) Inc. |
Controlled release subcutaneous implant
|
US5187150A
(en)
|
1987-10-14 |
1993-02-16 |
Debiopharm S.A. |
Polyester-based composition for the controlled release of polypeptide medicinal substances
|
US5120802A
(en)
|
1987-12-17 |
1992-06-09 |
Allied-Signal Inc. |
Polycarbonate-based block copolymers and devices
|
US5152781A
(en)
|
1987-12-17 |
1992-10-06 |
Allied-Signal Inc. |
Medical devices fabricated from homopolymers and copolymers having recurring carbonate units
|
US4898734A
(en)
*
|
1988-02-29 |
1990-02-06 |
Massachusetts Institute Of Technology |
Polymer composite for controlled release or membrane formation
|
US4902515A
(en)
*
|
1988-04-28 |
1990-02-20 |
E. I. Dupont De Nemours And Company |
Polylactide compositions
|
US5702716A
(en)
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
US5633002A
(en)
*
|
1988-10-04 |
1997-05-27 |
Boehringer Ingelheim Gmbh |
Implantable, biodegradable system for releasing active substance
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US4975280A
(en)
|
1989-01-23 |
1990-12-04 |
Ethyl Corporation |
Bioerodable sustained release implants
|
US5141748A
(en)
|
1989-02-17 |
1992-08-25 |
Hoffmann-La Roche, Inc. |
Implant drug delivery device
|
US6419655B1
(en)
|
1998-07-16 |
2002-07-16 |
Gonex, Inc. |
Method for controlling animal populations utilizing a sterilant projectile
|
US5019400A
(en)
*
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
EP0471036B2
(en)
|
1989-05-04 |
2004-06-23 |
Southern Research Institute |
Encapsulation process
|
US5178874A
(en)
*
|
1989-06-30 |
1993-01-12 |
Smithkline Beechman Corporation |
Intermittent release dosage form
|
US5273752A
(en)
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
CH679207A5
(pt)
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
US5225205A
(en)
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
US5439688A
(en)
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
MY107937A
(en)
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
US5290494A
(en)
|
1990-03-05 |
1994-03-01 |
Board Of Regents, The University Of Texas System |
Process of making a resorbable implantation device
|
US5668254A
(en)
|
1990-05-11 |
1997-09-16 |
Romano Deghenghi |
D-2-alkyl-tryptophan and peptides containing same
|
US5872100A
(en)
*
|
1990-05-11 |
1999-02-16 |
Deghenghi; Romano |
Peptides containing D-2-Alkyl-Tryptophan
|
GB9011767D0
(en)
|
1990-05-25 |
1990-07-18 |
Britannia Pharmaceuticals Ltd |
Pharmaceutical compositions
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
NZ239370A
(en)
|
1990-08-22 |
1994-04-27 |
Merck & Co Inc |
Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
|
US5164190A
(en)
|
1990-12-11 |
1992-11-17 |
Theratech, Inc. |
Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
|
MX9200038A
(es)
|
1991-01-09 |
1992-11-01 |
Alza Corp |
Dispositivos biodegradables y composiciones para la liberacion por difusion de agentes.
|
US5153002A
(en)
|
1991-03-04 |
1992-10-06 |
University Of Montreal |
Biocompatible gradient controlled release implant
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
US5800829A
(en)
|
1991-04-25 |
1998-09-01 |
Brown University Research Foundation |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
|
EP0585368B1
(en)
*
|
1991-04-25 |
1997-08-06 |
Brown University Research Foundation |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
|
US5486362A
(en)
|
1991-05-07 |
1996-01-23 |
Dynagen, Inc. |
Controlled, sustained release delivery system for treating drug dependency
|
US5403595A
(en)
|
1991-05-07 |
1995-04-04 |
Dynagen, Inc. |
Controlled, sustained release delivery system for smoking cessation
|
HU222501B1
(hu)
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
CH683149A5
(fr)
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
AU2605592A
(en)
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
DK0542364T3
(da)
|
1991-11-13 |
1996-03-11 |
Glaxo Canada |
Anordning til reguleret frigivelse
|
DE69212497T2
(de)
|
1991-12-05 |
1996-12-12 |
Mallinckrodt Veterinary Inc |
Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
|
US6013853A
(en)
*
|
1992-02-14 |
2000-01-11 |
The University Of Texas System |
Continuous release polymeric implant carrier
|
US5876452A
(en)
*
|
1992-02-14 |
1999-03-02 |
Board Of Regents, University Of Texas System |
Biodegradable implant
|
US5456679A
(en)
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
WO1993017662A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Daratech Pty. Ltd. |
Improved implants
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5656297A
(en)
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
US5429822A
(en)
|
1992-03-13 |
1995-07-04 |
Cambridge Scientific, Inc. |
Biodegradable bursting release system
|
GB9206504D0
(en)
|
1992-03-25 |
1992-05-06 |
Jevco Ltd |
Heteromorphic sponges as wound implants
|
ZA932273B
(en)
|
1992-03-30 |
1993-11-26 |
Alza Corp |
Additives for bioerodible polymers to regulate degradation
|
US5756117A
(en)
*
|
1992-04-08 |
1998-05-26 |
International Medical Asscociates, Inc. |
Multidose transdermal drug delivery system
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
US5518730A
(en)
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US5711968A
(en)
*
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
US6514533B1
(en)
*
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
FR2695826B1
(fr)
|
1992-09-21 |
1995-01-06 |
Theramex |
Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
|
GB9223144D0
(en)
*
|
1992-11-05 |
1992-12-16 |
Scherer Corp R P |
Controlled release device
|
DK0674506T3
(da)
|
1992-12-02 |
2001-01-08 |
Alkermes Inc |
Væksthormonholdige mikrosfærer med styret frigivelse
|
GB2273874A
(en)
*
|
1992-12-31 |
1994-07-06 |
Pertti Olavi Toermaelae |
Preparation of pharmaceuticals in a polymer matrix
|
US5429634A
(en)
|
1993-09-09 |
1995-07-04 |
Pdt Systems |
Biogenic implant for drug delivery and method
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5478355A
(en)
|
1993-03-18 |
1995-12-26 |
United States Surgical Corporation |
Method for improving the in vivo strength retention of a bioabsorbable implantable medical device and resulting medical device
|
US5382435A
(en)
|
1993-03-24 |
1995-01-17 |
Southwest Research Institute |
Microparticulate pharmaceutical delivery system
|
US5456917A
(en)
|
1993-04-12 |
1995-10-10 |
Cambridge Scientific, Inc. |
Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
|
DK0702723T3
(da)
|
1993-04-21 |
2003-01-13 |
Pasteur Institut |
Biokompatibelt implantat til ekspression og udskillelse af terapeutisk forbindelse in vivo
|
JPH07112940A
(ja)
*
|
1993-08-26 |
1995-05-02 |
Takeda Chem Ind Ltd |
徐放性非経口投与製剤およびその製造方法
|
IL110787A0
(en)
|
1993-08-27 |
1994-11-11 |
Sandoz Ag |
Biodegradable polymer, its preparation and pharmaceutical composition containing it
|
DE69426414T2
(de)
*
|
1993-09-24 |
2001-05-03 |
Takiron Co |
Implantatmaterial
|
US5681873A
(en)
|
1993-10-14 |
1997-10-28 |
Atrix Laboratories, Inc. |
Biodegradable polymeric composition
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
JP3720386B2
(ja)
|
1993-12-27 |
2005-11-24 |
住友製薬株式会社 |
薬物放出制御製剤
|
US5554147A
(en)
*
|
1994-02-01 |
1996-09-10 |
Caphco, Inc. |
Compositions and devices for controlled release of active ingredients
|
US5626611A
(en)
|
1994-02-10 |
1997-05-06 |
United States Surgical Corporation |
Composite bioabsorbable materials and surgical articles made therefrom
|
CA2190121A1
(en)
|
1994-03-15 |
1995-09-21 |
Edith Mathiowitz |
Polymeric gene delivery system
|
BR9507313A
(pt)
|
1994-04-08 |
1997-10-07 |
Atrix Lab Inc |
Composição liquida de liberação adequada para a formação de um implante de liberação controlada sistema polimérico curativo filmico microporoso biodegradável precursor de implante de liberação controlada para a implantação em um indivíduo polímero termoplástico solvente orgánico composicão de pré-polimero liquido componente de liberação controlada agente ativo uso da composição liquida de liberação e processos para forma um implante microporoso de liberação prolongada e para liberar um agente ativo em um individuo
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6855331B2
(en)
*
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US5958458A
(en)
|
1994-06-15 |
1999-09-28 |
Dumex-Alpharma A/S |
Pharmaceutical multiple unit particulate formulation in the form of coated cores
|
US5633000A
(en)
*
|
1994-06-23 |
1997-05-27 |
Axxia Technologies |
Subcutaneous implant
|
US5817327A
(en)
|
1994-07-27 |
1998-10-06 |
The Trustees Of The University Of Pennsylvania |
Incorporation of biologically active molecules into bioactive glasses
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5681568A
(en)
|
1994-08-19 |
1997-10-28 |
Cambridge Neuroscience, Inc. |
Device for delivery of substances and methods of use thereof
|
ATE225806T1
(de)
|
1994-09-27 |
2002-10-15 |
Bioscience Limited Ardana |
D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
|
AUPM897594A0
(en)
|
1994-10-25 |
1994-11-17 |
Daratech Pty Ltd |
Controlled release container
|
US6395303B1
(en)
|
1996-06-10 |
2002-05-28 |
Edward Mendell Co., Inc. |
Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
|
JPH10513471A
(ja)
|
1995-02-10 |
1998-12-22 |
メドトロニック、インコーポレイテッド |
鎮痛薬投与のための方法と装置
|
US5900425A
(en)
|
1995-05-02 |
1999-05-04 |
Bayer Aktiengesellschaft |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
CN1156961A
(zh)
|
1995-06-09 |
1997-08-13 |
欧罗赛铁克股份有限公司 |
产生长效局部麻醉的制剂和方法
|
US6245347B1
(en)
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US5705191A
(en)
*
|
1995-08-18 |
1998-01-06 |
The United States Of America As Represented By The Secretary Of The Navy |
Sustained delivery of active compounds from tubules, with rational control
|
US6265389B1
(en)
*
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
EP0850051A2
(en)
|
1995-08-31 |
1998-07-01 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
FI954565A0
(fi)
|
1995-09-27 |
1995-09-27 |
Biocon Oy |
Biolgiskt upploeslig av ett polymerbaserat material tillverkad implant och foerfarande foer dess tillverkning
|
AUPN605795A0
(en)
*
|
1995-10-19 |
1995-11-09 |
F.H. Faulding & Co. Limited |
Analgesic pharmaceutical composition
|
US5965125A
(en)
|
1995-10-25 |
1999-10-12 |
Transkaryotic Therapies, Inc. |
Hybrid matrix implants and explants
|
US6419920B1
(en)
|
1995-10-25 |
2002-07-16 |
Trans Karyotic Therapies, Inc. |
Hybrid matrix implants and explants
|
ATE284202T1
(de)
|
1996-02-02 |
2004-12-15 |
Alza Corp |
Implantierbares system mit verzögerter wirkstofffreisetzung
|
US6156331A
(en)
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
DE19608423A1
(de)
|
1996-03-05 |
1997-09-11 |
Merck Patent Gmbh |
Implantate mit phasenweiser Arzneistoffabgabe
|
US6299895B1
(en)
*
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US5747060A
(en)
*
|
1996-03-26 |
1998-05-05 |
Euro-Celtique, S.A. |
Prolonged local anesthesia with colchicine
|
FR2748205A1
(fr)
|
1996-05-06 |
1997-11-07 |
Debio Rech Pharma Sa |
Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
|
US5817343A
(en)
|
1996-05-14 |
1998-10-06 |
Alkermes, Inc. |
Method for fabricating polymer-based controlled-release devices
|
DE19622355A1
(de)
*
|
1996-06-04 |
1997-12-11 |
Bayer Ag |
Formkörper die agrochemische Mittel freisetzen
|
US5807985A
(en)
|
1996-06-11 |
1998-09-15 |
Deghenghi; Romano |
Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US5945128A
(en)
|
1996-09-04 |
1999-08-31 |
Romano Deghenghi |
Process to manufacture implants containing bioactive peptides
|
DE19701912C1
(de)
|
1997-01-10 |
1998-05-14 |
Jenapharm Gmbh |
Injizierbares Implantat
|
US6203813B1
(en)
*
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
FR2762318B1
(fr)
|
1997-04-18 |
1999-09-17 |
Pharma Biotech |
Compositions presentant une liberation prolongee et leur procede de preparation
|
ES2285770T3
(es)
|
1997-05-12 |
2007-11-16 |
Metabolix, Inc. |
Polihidroxialcanoato para aplicaciones en vivo.
|
US5945284A
(en)
|
1997-05-27 |
1999-08-31 |
The Perkin-Elmer Corporation |
Length determination of nucleic acid repeat sequences by discontinuous primer extension
|
US5874098A
(en)
*
|
1997-05-28 |
1999-02-23 |
Ivy Laboratories, Inc. |
Pellet implant system
|
JP2002511075A
(ja)
|
1997-06-04 |
2002-04-09 |
デビオ ルシェルシュ ファルマスティク ソシエテ アノニム |
薬学的活性成分の制御放出のためのインプラント及びその製造方法
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
CN1271277A
(zh)
|
1997-07-18 |
2000-10-25 |
因菲米德有限公司 |
用于生物活性物质控释的生物可降解的大分子的单体
|
US6828357B1
(en)
|
1997-07-31 |
2004-12-07 |
Metabolix, Inc. |
Polyhydroxyalkanoate compositions having controlled degradation rates
|
CN1277550A
(zh)
|
1997-09-11 |
2000-12-20 |
尼科梅德丹麦有限公司 |
非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
|
US6120788A
(en)
*
|
1997-10-16 |
2000-09-19 |
Bioamide, Inc. |
Bioabsorbable triglycolic acid poly(ester-amide)s
|
CA2221195A1
(en)
|
1997-11-14 |
1999-05-14 |
Chantal E. Holy |
Biodegradable polymer matrix
|
US6472210B1
(en)
|
1997-11-14 |
2002-10-29 |
Bonetec Corporation |
Polymer scaffold having microporous polymer struts defining interconnected macropores
|
US6187329B1
(en)
*
|
1997-12-23 |
2001-02-13 |
Board Of Regents Of The University Of Texas System |
Variable permeability bone implants, methods for their preparation and use
|
PL343432A1
(en)
|
1998-03-02 |
2001-08-13 |
Applied Vaccine Technologies C |
Methods and devices for modulating the immune response
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US6296831B1
(en)
*
|
1998-04-10 |
2001-10-02 |
Battelle Memorial Institute |
Stimulus sensitive gel with radioisotope and methods of making
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
US6129757A
(en)
|
1998-05-18 |
2000-10-10 |
Scimed Life Systems |
Implantable members for receiving therapeutically useful compositions
|
TW586944B
(en)
|
1998-05-29 |
2004-05-11 |
Sumitomo Pharma |
Controlled release agent having a multi-layer structure
|
US6117441A
(en)
|
1998-07-02 |
2000-09-12 |
The Population Council, Inc. |
Silicone core long term androgen delivery implant
|
ATE428371T1
(de)
|
1998-07-17 |
2009-05-15 |
Pacira Pharmaceuticals Inc |
Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
|
DE59913045D1
(de)
|
1998-08-06 |
2006-04-06 |
Schierholz Joerg Michael |
Medizinprodukte mit retardierter pharmakologischer aktivität und verfahren zu ihrer herstellung
|
US20040126404A1
(en)
|
1998-08-21 |
2004-07-01 |
University Of Queensland Of St. Lucia |
Implant material
|
US6335029B1
(en)
|
1998-08-28 |
2002-01-01 |
Scimed Life Systems, Inc. |
Polymeric coatings for controlled delivery of active agents
|
JP2003524444A
(ja)
|
1998-09-10 |
2003-08-19 |
パーカーディア,インコーポレイティド |
Tmrシャント
|
US6143314A
(en)
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
US6565874B1
(en)
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
US6063395A
(en)
|
1998-11-12 |
2000-05-16 |
Leiras Oy |
Drug delivery device especially for the delivery of progestins and estrogens
|
US6117442A
(en)
|
1998-11-12 |
2000-09-12 |
Leiras Oy |
Drug delivery device, especially for the delivery of androgens
|
US6165486A
(en)
|
1998-11-19 |
2000-12-26 |
Carnegie Mellon University |
Biocompatible compositions and methods of using same
|
IT1304152B1
(it)
|
1998-12-10 |
2001-03-08 |
Mediolanum Farmaceutici Srl |
Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
|
US6692520B1
(en)
|
1998-12-15 |
2004-02-17 |
C. R. Bard, Inc. |
Systems and methods for imbedded intramuscular implants
|
US6455526B1
(en)
|
1998-12-16 |
2002-09-24 |
Aventis Pharmaceuticals, Inc. |
Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
|
US6696073B2
(en)
*
|
1999-02-23 |
2004-02-24 |
Osteotech, Inc. |
Shaped load-bearing osteoimplant and methods of making same
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
ATE319421T1
(de)
|
1999-05-27 |
2006-03-15 |
Biocompatibles Uk Ltd |
Lokale arzneistoffabgabe
|
US6541020B1
(en)
|
1999-07-09 |
2003-04-01 |
Trimeris, Inc. |
Methods and compositions for administration of therapeutic reagents
|
US6309660B1
(en)
|
1999-07-28 |
2001-10-30 |
Edwards Lifesciences Corp. |
Universal biocompatible coating platform for medical devices
|
US6855160B1
(en)
|
1999-08-04 |
2005-02-15 |
C. R. Bard, Inc. |
Implant and agent delivery device
|
EP1206254A1
(en)
|
1999-08-06 |
2002-05-22 |
The Board Of Regents, The University Of Texas System |
Drug releasing biodegradable fiber implant
|
FI19991852A
(fi)
*
|
1999-09-01 |
2001-03-01 |
Yli Urpo Antti |
Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
|
JP4172883B2
(ja)
*
|
1999-09-08 |
2008-10-29 |
Hoya株式会社 |
薬物徐放用担体および薬物徐放用担体の製造方法
|
US6573311B1
(en)
|
1999-09-22 |
2003-06-03 |
Atrium Medical Corporation |
Method for treating polymer materials and products produced therefrom
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
US6461631B1
(en)
*
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US6579533B1
(en)
|
1999-11-30 |
2003-06-17 |
Bioasborbable Concepts, Ltd. |
Bioabsorbable drug delivery system for local treatment and prevention of infections
|
US20040009228A1
(en)
|
1999-11-30 |
2004-01-15 |
Pertti Tormala |
Bioabsorbable drug delivery system for local treatment and prevention of infections
|
US20020131988A1
(en)
|
1999-12-16 |
2002-09-19 |
Foster Todd P. |
Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
|
AU3289301A
(en)
*
|
2000-01-20 |
2001-07-31 |
Delsys Pharmaceutical Corporation |
Multi-step drug dosage forms
|
TW200800298A
(en)
|
2000-01-27 |
2008-01-01 |
Zentaris Ag |
Compressed microparticles for dry injection
|
CA2398668C
(en)
|
2000-02-17 |
2010-06-15 |
3M Innovative Properties Company |
Delivery systems using preformed biodegradable polymer compositions and methods
|
US20040175410A1
(en)
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
US6375972B1
(en)
*
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US20040208910A1
(en)
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
US7300662B2
(en)
|
2000-05-12 |
2007-11-27 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
US20050002986A1
(en)
*
|
2000-05-12 |
2005-01-06 |
Robert Falotico |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
US20040243097A1
(en)
|
2000-05-12 |
2004-12-02 |
Robert Falotico |
Antiproliferative drug and delivery device
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
KR100392501B1
(ko)
*
|
2000-06-28 |
2003-07-22 |
동국제약 주식회사 |
다중 에멀젼법에 의한 서방출성 미립구의 제조방법
|
US6767550B1
(en)
|
2000-06-30 |
2004-07-27 |
Berkeley Advanced Biomaterials, Inc. |
Hydroxyapatite based drug delivery implant for cancer treatment
|
US8158143B2
(en)
|
2000-07-14 |
2012-04-17 |
Helmholtz-Zentrum Geesthacht Zentrum Fuer Material- Und Kuestenforschung Gmbh |
Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect
|
US6669959B1
(en)
|
2000-07-18 |
2003-12-30 |
Aeropharm Technology Incorporated |
Modulated release particles for lung delivery
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6479065B2
(en)
*
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
DE10044545A1
(de)
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
US6953560B1
(en)
|
2000-09-28 |
2005-10-11 |
Advanced Cardiovascular Systems, Inc. |
Barriers for polymer-coated implantable medical devices and methods for making the same
|
WO2002028366A2
(en)
|
2000-10-06 |
2002-04-11 |
Durect Corporation |
Devices and methods for management of inflammation
|
US6783793B1
(en)
|
2000-10-26 |
2004-08-31 |
Advanced Cardiovascular Systems, Inc. |
Selective coating of medical devices
|
US6746661B2
(en)
|
2000-11-16 |
2004-06-08 |
Microspherix Llc |
Brachytherapy seed
|
US6545097B2
(en)
*
|
2000-12-12 |
2003-04-08 |
Scimed Life Systems, Inc. |
Drug delivery compositions and medical devices containing block copolymer
|
US20030049320A1
(en)
|
2000-12-18 |
2003-03-13 |
Wockhardt Limited |
Novel in-situ forming controlled release microcarrier delivery system
|
US20020119179A1
(en)
|
2000-12-22 |
2002-08-29 |
Alireza Rezania |
Implantable biodegradable devices for musculoskeletal repair or regeneration
|
US7192604B2
(en)
|
2000-12-22 |
2007-03-20 |
Ethicon, Inc. |
Implantable biodegradable devices for musculoskeletal repair or regeneration
|
US6939375B2
(en)
|
2000-12-22 |
2005-09-06 |
Avantac Vascular Corporation |
Apparatus and methods for controlled substance delivery from implanted prostheses
|
WO2002056863A2
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
US6719935B2
(en)
|
2001-01-05 |
2004-04-13 |
Howmedica Osteonics Corp. |
Process for forming bioabsorbable implants
|
US6524615B2
(en)
|
2001-02-21 |
2003-02-25 |
Kos Pharmaceuticals, Incorporated |
Controlled release pharmaceutical composition
|
US20020131953A1
(en)
|
2001-03-14 |
2002-09-19 |
Ut Southwestern Medical Center |
In situ langerhans cell vaccine
|
DE10114247A1
(de)
|
2001-03-22 |
2002-10-10 |
Heraeus Kulzer Gmbh & Co Kg |
Antibiotikum-/Antibiotika-Polymer-Kombination
|
DE10114244A1
(de)
|
2001-03-22 |
2002-10-02 |
Heraeus Kulzer Gmbh & Co Kg |
Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
|
EP1247537A1
(en)
|
2001-04-04 |
2002-10-09 |
Isotis B.V. |
Coating for medical devices
|
US6913762B2
(en)
|
2001-04-25 |
2005-07-05 |
Mayo Foundation For Medical Education And Research |
Stent having non-woven framework containing cells
|
US20020168393A1
(en)
|
2001-05-08 |
2002-11-14 |
Ryota Sugimoto |
Implantable medical material and implantable medical device
|
JP2004535431A
(ja)
*
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
US6648849B2
(en)
|
2001-06-27 |
2003-11-18 |
Ethicon, Inc. |
Medicinal implant and device and method for loading and delivering implants containing drugs and cells
|
BR0210722A
(pt)
|
2001-06-29 |
2004-07-20 |
Medgraft Microtech Inc |
Implantes injetáveis biodegradáveis e métodos relacionados de produção e uso
|
AUPR602401A0
(en)
|
2001-06-29 |
2001-07-26 |
Smart Drug Systems Inc |
Sustained release delivery system
|
AUPR602501A0
(en)
|
2001-06-29 |
2001-07-26 |
Smart Drug Systems Inc |
Sustained release pharmaceutical composition
|
US6921390B2
(en)
|
2001-07-23 |
2005-07-26 |
Boston Scientific Scimed, Inc. |
Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface
|
US6913760B2
(en)
|
2001-08-06 |
2005-07-05 |
New England Medical Hospitals, Inc. |
Drug delivery composition
|
US7056338B2
(en)
*
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
US6669955B2
(en)
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
BR0212052A
(pt)
|
2001-09-11 |
2004-08-17 |
Smart Drug Systems Inc |
Preparação de composição farmacêutica de liberação prolongada
|
GB0122113D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Composition
|
GB2379390B
(en)
|
2001-09-11 |
2005-01-26 |
Caretek Medical Ltd |
A novel drug delivery technology
|
US20050129728A1
(en)
|
2001-09-11 |
2005-06-16 |
Martinod Serge R. |
Sustained release pharmaceutical composition
|
IN2014DN10834A
(pt)
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
US20030158598A1
(en)
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
US7285304B1
(en)
*
|
2003-06-25 |
2007-10-23 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
US20030229390A1
(en)
|
2001-09-17 |
2003-12-11 |
Control Delivery Systems, Inc. |
On-stent delivery of pyrimidines and purine analogs
|
US6827737B2
(en)
*
|
2001-09-25 |
2004-12-07 |
Scimed Life Systems, Inc. |
EPTFE covering for endovascular prostheses and method of manufacture
|
JP2005505351A
(ja)
|
2001-10-12 |
2005-02-24 |
オステオテック インコーポレーテッド |
改善された骨移植片
|
US6926903B2
(en)
|
2001-12-04 |
2005-08-09 |
Inion Ltd. |
Resorbable polymer composition, implant and method of making implant
|
CA2497195C
(en)
|
2001-12-14 |
2014-07-08 |
The University Of Wyoming |
Methods and compositions for controlled release of drugs
|
US8454997B2
(en)
*
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
CA2473355C
(en)
|
2002-01-18 |
2012-01-03 |
Michael E. Snyder |
Sustained release ophthalmological device and method of making and using the same
|
JP2005522418A
(ja)
|
2002-01-24 |
2005-07-28 |
スマート ドラッグ システムズ インコーポレイティド |
徐放性医薬組成物
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
US6887270B2
(en)
|
2002-02-08 |
2005-05-03 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical device resistant to microbial growth and biofilm formation
|
DE10208335A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
WO2003092791A2
(en)
|
2002-05-02 |
2003-11-13 |
Scimed Life Systems, Inc. |
Energetically-controlled delivery of biologically active material from an implanted medical device
|
US7736665B2
(en)
|
2002-05-31 |
2010-06-15 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine
|
NZ519363A
(en)
|
2002-06-05 |
2004-02-27 |
Agres Ltd |
A novel drug dosing regimen
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
US7105175B2
(en)
|
2002-06-19 |
2006-09-12 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled delivery of a therapeutic agent
|
US7101566B2
(en)
|
2002-06-28 |
2006-09-05 |
Ethicon, Inc. |
Polymer coated microparticles for sustained release
|
US20040006146A1
(en)
|
2002-07-06 |
2004-01-08 |
Evans Douglas G. |
Resorbable structure for treating and healing of tissue defects
|
US7049348B2
(en)
|
2002-07-06 |
2006-05-23 |
Kensey Nash Corporation |
Resorbable structure for treating and healing of tissue defects
|
US6916483B2
(en)
|
2002-07-22 |
2005-07-12 |
Biodynamics, Llc |
Bioabsorbable plugs containing drugs
|
CA2494230C
(en)
|
2002-07-31 |
2012-03-06 |
Macropore Biosurgery, Inc. |
Apparatus and method for preventing adhesions between an implant and surrounding tissues
|
US20040086569A1
(en)
|
2002-08-13 |
2004-05-06 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
US7951392B2
(en)
*
|
2002-08-16 |
2011-05-31 |
Boston Scientific Scimed, Inc. |
Microarray drug delivery coatings
|
US7438925B2
(en)
|
2002-08-26 |
2008-10-21 |
Biovention Holdings Ltd. |
Drug eluting coatings for medical implants
|
AU2003265866A1
(en)
|
2002-09-03 |
2004-03-29 |
Vit Lauermann |
Targeted release
|
DE10242476B4
(de)
|
2002-09-11 |
2006-10-26 |
Heraeus Kulzer Gmbh |
Antibiotikum-/Antibiotika-Polymer-Kombination
|
CA2503490C
(en)
|
2002-10-21 |
2012-04-03 |
Allvivo, Inc. |
Medical device surface coating comprising bioactive compound
|
BR0315304A
(pt)
|
2002-11-06 |
2005-08-16 |
Alza Corp |
Formulações com depósito para liberação controlada
|
US20050070989A1
(en)
*
|
2002-11-13 |
2005-03-31 |
Whye-Kei Lye |
Medical devices having porous layers and methods for making the same
|
US20060121080A1
(en)
|
2002-11-13 |
2006-06-08 |
Lye Whye K |
Medical devices having nanoporous layers and methods for making the same
|
US7758881B2
(en)
|
2004-06-30 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
US20040143221A1
(en)
|
2002-12-27 |
2004-07-22 |
Shadduck John H. |
Biomedical implant for sustained agent release
|
WO2004060424A2
(en)
*
|
2002-12-30 |
2004-07-22 |
Angiotech International Ag |
Silk-containing stent graft
|
US7985414B2
(en)
|
2003-02-04 |
2011-07-26 |
Warsaw Orthopedic, Inc. |
Polyurethanes for osteoimplants
|
US20050079199A1
(en)
|
2003-02-18 |
2005-04-14 |
Medtronic, Inc. |
Porous coatings for drug release from medical devices
|
US20080051866A1
(en)
*
|
2003-02-26 |
2008-02-28 |
Chao Chin Chen |
Drug delivery devices and methods
|
US20060083767A1
(en)
|
2003-02-27 |
2006-04-20 |
Kai Deusch |
Surgical prosthesis having biodegradable and nonbiodegradable regions
|
GB0304726D0
(en)
|
2003-03-01 |
2003-04-02 |
Ardana Bioscience Ltd |
New Process
|
US8313759B2
(en)
|
2003-03-06 |
2012-11-20 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent
|
BRPI0407818A
(pt)
|
2003-03-14 |
2006-02-14 |
Debio Rech Pharma Sa |
sistema de distribuição subcutánea, processo para a preparação do mesmo e uso do mesmo para o tratamento das doenças da deficiência colinérgica
|
NZ542548A
(en)
|
2003-03-31 |
2009-04-30 |
Titan Pharmaceuticals Inc |
Implantable polymeric device for sustained release of dopamine agonist
|
US8007823B2
(en)
|
2003-04-03 |
2011-08-30 |
Corporation De L'ecole Polytechnique De Montreal |
Microporous articles comprising biodegradable medical polymers, method of preparation thereof and method of use thereof
|
US7241455B2
(en)
|
2003-04-08 |
2007-07-10 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent
|
US20060105018A1
(en)
|
2004-11-17 |
2006-05-18 |
Epstein Samuel J |
Therapeutic driving layer for a medical device
|
CA2524271C
(en)
*
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
US20040224000A1
(en)
|
2003-05-05 |
2004-11-11 |
Romano Deghenghi |
Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
|
ES2819189T3
(es)
|
2003-05-08 |
2021-04-15 |
Tepha Inc |
Tejidos y fibras médicos de polihidroxialcanoato
|
KR20060003100A
(ko)
|
2003-05-16 |
2006-01-09 |
블루 멤브레인스 게엠베하 |
생체적합성 코팅제를 포함하는 의료용 이식물
|
WO2004110400A2
(en)
|
2003-05-30 |
2004-12-23 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of nalmefene
|
AU2003233838A1
(en)
|
2003-06-04 |
2005-01-04 |
Inion Ltd |
Biodegradable implant and method for manufacturing one
|
US20040253293A1
(en)
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
ITMI20031302A1
(it)
|
2003-06-26 |
2004-12-27 |
Mediolanum Pharmaceuticals Ltd |
Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.
|
PT1638535E
(pt)
|
2003-06-26 |
2007-11-08 |
Mediolanum Pharmaceuticals Ltd |
Implantes subcutâneos com libertação inicial de princípio activo limitada e subsequente sua libertação extensiva com variação linear
|
US7220433B2
(en)
|
2003-06-27 |
2007-05-22 |
Ethicon, Inc. |
Compositions for parenteral administration and sustained-release of therapeutic agents
|
FI20045223A
(fi)
|
2004-06-15 |
2005-12-16 |
Bioretec Oy |
Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin
|
US20060240071A1
(en)
|
2003-07-31 |
2006-10-26 |
Sidney Lerner |
Non-hormonal vaginal contraceptive
|
US7357940B2
(en)
|
2003-07-31 |
2008-04-15 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing graft copolymer for controlled delivery of therapeutic agents
|
US8870814B2
(en)
|
2003-07-31 |
2014-10-28 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing silicone copolymer for controlled delivery of therapeutic agent
|
US9114199B2
(en)
|
2003-07-31 |
2015-08-25 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
|
US7914805B2
(en)
|
2003-07-31 |
2011-03-29 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing radiation-treated polymer for improved delivery of therapeutic agent
|
US7169405B2
(en)
|
2003-08-06 |
2007-01-30 |
Warsaw Orthopedic, Inc. |
Methods and devices for the treatment of intervertebral discs
|
US20050037047A1
(en)
|
2003-08-11 |
2005-02-17 |
Young-Ho Song |
Medical devices comprising spray dried microparticles
|
US8529625B2
(en)
|
2003-08-22 |
2013-09-10 |
Smith & Nephew, Inc. |
Tissue repair and replacement
|
WO2005034726A2
(en)
|
2003-09-23 |
2005-04-21 |
Ortho Therapeutics, Llc |
Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
|
WO2005039668A2
(en)
|
2003-10-21 |
2005-05-06 |
Boiarski Anthony A |
Implantable drug delivery device for sustained release of therapeutic agent
|
US7435256B2
(en)
|
2003-11-06 |
2008-10-14 |
Boston Scientific Scimed, Inc. |
Method and apparatus for controlled delivery of active substance
|
US20050208095A1
(en)
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
CA2536188A1
(en)
|
2003-11-20 |
2005-06-09 |
Angiotech International Ag |
Electrical devices and anti-scarring agents
|
US8747881B2
(en)
|
2003-12-19 |
2014-06-10 |
Cordis Corporation |
Intraluminal medical devices in combination with therapeutic agents
|
US20050249776A1
(en)
|
2003-12-19 |
2005-11-10 |
Chen Chao C |
Coated aneurysmal repair device
|
WO2005067889A1
(en)
|
2003-12-30 |
2005-07-28 |
Durect Corporation |
Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
|
US8329203B2
(en)
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US7303758B2
(en)
|
2004-01-20 |
2007-12-04 |
Cordis Corporation |
Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury
|
US20050181015A1
(en)
|
2004-02-12 |
2005-08-18 |
Sheng-Ping (Samuel) Zhong |
Layered silicate nanoparticles for controlled delivery of therapeutic agents from medical articles
|
US20050181047A1
(en)
|
2004-02-18 |
2005-08-18 |
Jaime Romero |
Compositions and methods for timed release of water-soluble nutritional supplements
|
US7806924B2
(en)
|
2004-02-18 |
2010-10-05 |
Cordis Corporation |
Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis
|
US8828416B2
(en)
|
2004-03-09 |
2014-09-09 |
Cordis Corporation |
Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury
|
US7695731B2
(en)
|
2004-03-22 |
2010-04-13 |
Cordis Corporation |
Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury
|
US7034050B2
(en)
|
2004-04-28 |
2006-04-25 |
Romano Deghenghi |
Pseudopeptides growth hormone secretagogues
|
US20050244461A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
US20070059336A1
(en)
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20050244465A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20060018948A1
(en)
|
2004-06-24 |
2006-01-26 |
Guire Patrick E |
Biodegradable implantable medical devices, methods and systems
|
EP1809349B1
(en)
*
|
2004-07-05 |
2009-10-14 |
Ziscoat N.V. |
Biocompatible coating of medical devices comprising molecular sieves
|
EP1629844B2
(en)
*
|
2004-07-13 |
2012-04-18 |
Bayer Schering Pharma Oy |
A longterm delivery system with controlled initial burst
|
US7771740B2
(en)
|
2004-07-19 |
2010-08-10 |
Boston Scientific Scimed, Inc. |
Medical devices containing copolymers with graft copolymer endblocks for drug delivery
|
US7713539B2
(en)
|
2004-07-19 |
2010-05-11 |
Boston Scientific Scimed, Inc. |
Medical devices containing radiation resistant block copolymer
|
AU2005325213B2
(en)
|
2004-08-04 |
2010-10-07 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
CN101018512B
(zh)
|
2004-08-13 |
2011-05-18 |
马斯特生物外科股份公司 |
具有可生物降解区和不可生物降解区的外科手术假体
|
US20060039946A1
(en)
|
2004-08-20 |
2006-02-23 |
Medtronic Inc. |
Drug eluting medical device
|
US20060051390A1
(en)
|
2004-09-03 |
2006-03-09 |
Schwarz Marlene C |
Medical devices having self-forming rate-controlling barrier for drug release
|
AU2005292145C1
(en)
|
2004-10-01 |
2011-07-21 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
CA2582374A1
(en)
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
US20060093643A1
(en)
|
2004-11-04 |
2006-05-04 |
Stenzel Eric B |
Medical device for delivering therapeutic agents over different time periods
|
US20060134168A1
(en)
|
2004-12-07 |
2006-06-22 |
Chappa Ralph A |
Coatings with crystallized active agent(s) and methods
|
EP1835885A1
(en)
|
2004-12-23 |
2007-09-26 |
Durect Corporation |
Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh
|
US20060147491A1
(en)
|
2005-01-05 |
2006-07-06 |
Dewitt David M |
Biodegradable coating compositions including multiple layers
|
US20060198868A1
(en)
|
2005-01-05 |
2006-09-07 |
Dewitt David M |
Biodegradable coating compositions comprising blends
|
US7988987B2
(en)
|
2005-01-25 |
2011-08-02 |
Boston Scientific Scimed, Inc. |
Medical devices containing crazed polymeric release regions for drug delivery
|
US8075906B2
(en)
|
2005-02-01 |
2011-12-13 |
Boston Scientific Scimed, Inc. |
Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species
|
US20060171980A1
(en)
|
2005-02-01 |
2006-08-03 |
Helmus Michael N |
Implantable or insertable medical devices having optimal surface energy
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
US20060177480A1
(en)
|
2005-02-10 |
2006-08-10 |
Hsing-Wen Sung |
Drug-eluting biodegradable stent
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
EP1879552B1
(en)
|
2005-03-14 |
2016-02-17 |
Biotegra, Inc. |
Drug delivery compositions comprising a polyelectrolyte complex within a polymeric matrix
|
US7857856B2
(en)
|
2005-03-15 |
2010-12-28 |
Warsaw Ortho Pedic, Inc. |
Composite spinal nucleus implant with water absorption and swelling capabilities
|
US7517914B2
(en)
|
2005-04-04 |
2009-04-14 |
Boston Scientificscimed, Inc. |
Controlled degradation materials for therapeutic agent delivery
|
WO2006110487A1
(en)
|
2005-04-08 |
2006-10-19 |
Surmodics, Inc. |
Sustained release implants for subretinal delivery
|
US20060257448A1
(en)
|
2005-05-10 |
2006-11-16 |
The University Of Zurich |
Resorbable polymer composition, implant and method of making implant
|
US20070009564A1
(en)
|
2005-06-22 |
2007-01-11 |
Mcclain James B |
Drug/polymer composite materials and methods of making the same
|
WO2007001624A2
(en)
|
2005-06-28 |
2007-01-04 |
Microchips, Inc. |
Medical and dental implant devices for controlled drug delivery
|
US8722074B2
(en)
|
2005-07-19 |
2014-05-13 |
Boston Scientific Scimed, Inc. |
Medical devices containing radiation resistant polymers
|
US20070048350A1
(en)
*
|
2005-08-31 |
2007-03-01 |
Robert Falotico |
Antithrombotic coating for drug eluting medical devices
|
US20070053952A1
(en)
|
2005-09-07 |
2007-03-08 |
Medtronic Vascular, Inc. |
Nitric oxide-releasing polymers derived from modified polymers
|
WO2007038246A2
(en)
*
|
2005-09-22 |
2007-04-05 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
US8784860B2
(en)
|
2005-10-27 |
2014-07-22 |
Cordis Corporation |
Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease
|
US20070196423A1
(en)
|
2005-11-21 |
2007-08-23 |
Med Institute, Inc. |
Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
|
US20070116736A1
(en)
|
2005-11-23 |
2007-05-24 |
Argentieri Dennis C |
Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury
|
JP5247468B2
(ja)
|
2005-12-30 |
2013-07-24 |
ニューロテック ユーエスエー, インコーポレイテッド |
生物活性分子の送達のための微粒子化デバイスおよびその使用方法
|
US7910152B2
(en)
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
US20070212388A1
(en)
|
2006-03-08 |
2007-09-13 |
Sahajanand Medical Technologies Pvt. Ltd. |
Compositions comprising porous articles and uses in implantable medical devices
|
US20070224239A1
(en)
|
2006-03-27 |
2007-09-27 |
Niall Behan |
Method of making a coated medical device
|
KR20110038144A
(ko)
|
2006-03-31 |
2011-04-13 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
비루관계에 대한 약물 전달 방법, 구조, 및 조성물
|
JP2009540936A
(ja)
|
2006-06-22 |
2009-11-26 |
ユニバーシティー オブ サウス フロリダ |
コラーゲン足場、それを伴う医療用埋植物、およびその使用方法
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
JP2009542671A
(ja)
*
|
2006-06-28 |
2009-12-03 |
サーモディクス,インコーポレイティド |
微粒子を含む活性剤溶出マトリックス
|
US7731987B2
(en)
*
|
2006-07-13 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US8506984B2
(en)
*
|
2006-07-26 |
2013-08-13 |
Cordis Corporation |
Therapeutic agent elution control process
|
US9248121B2
(en)
*
|
2006-08-21 |
2016-02-02 |
Abbott Laboratories |
Medical devices for controlled drug release
|
WO2008039749A2
(en)
*
|
2006-09-25 |
2008-04-03 |
Surmodics, Inc. |
Multi-layered coatings and methods for controlling elution of active agents
|
RU2012115120A
(ru)
|
2009-09-17 |
2013-10-27 |
Евоник Дегусса Корпорейшн |
Имплантируемые устройства, которые отличаются профилем высвобождения, и способы их изготовления и применения
|
KR20120102606A
(ko)
|
2009-09-22 |
2012-09-18 |
에보닉 데구사 코포레이션 |
생리활성 물질의 방출 프로파일을 조절하기 위한 임플란트 장치
|
BR112012006443A2
(pt)
|
2009-09-22 |
2017-07-25 |
Evonik Degussa Corp |
dispositivos de implante que apresentam configurações de cargas variáveis de agentes bioativos
|